NCT02579889

Brief Summary

The study is designed as a multi-center, international, prospective, parallel, randomized, single blinded trial comparing the time to first primary endpoint event (Sustained Paroxysmal AF/Persistent AF or stroke/TIA) occurrence in a follow up period of 3 years, between Closed Loop Stimulation (CLS) ON versus OFF, on top of a DDD pacing in patients with pacemaker or ICD indication who require dual-chamber pacing due to sinus node disease (SND), with or without atrioventricular (AV) block.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,390

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
9 countries

54 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 16, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 20, 2015

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

January 18, 2024

Status Verified

January 1, 2024

Enrollment Period

7.5 years

First QC Date

October 16, 2015

Last Update Submit

January 15, 2024

Conditions

Keywords

Closed Loop StimulationAtrial FibrillationStrokeHeart FailurePacemakerICD

Outcome Measures

Primary Outcomes (1)

  • First event of Sustained Paroxysmal AF or Persistent AF or stroke or TIA, whichever comes first.

    three years

Secondary Outcomes (6)

  • Sustained Paroxysmal AF (SPAF)

    Three years

  • Persistent AF

    Three years

  • Permanent AF

    Three years

  • Stroke/TIA

    Three years

  • Worsening Heart failure Hospitalization (wHF-H)

    Three years

  • +1 more secondary outcomes

Study Arms (2)

Active group - CLS ON

EXPERIMENTAL

Device will be programmed in a dual-chamber DDD pacing mode with the Closed Loop Stimulation (CLS) function ON; Intervention: DDD+CLS

Device: DDD+CLS

Control group - CLS OFF

ACTIVE COMPARATOR

Device will be programmed in a dual-chamber DDD(R) pacing mode with the Closed Loop Stimulation (CLS) function OFF

Device: DDD(R)

Interventions

DDD+CLSDEVICE

Device will be programmed in a dual-chamber DDD pacing mode with the Closed Loop Stimulation (CLS) function ON

Active group - CLS ON
DDD(R)DEVICE

Device will be programmed in a dual-chamber DDD(R) pacing mode with the Closed Loop Stimulation (CLS) function OFF

Control group - CLS OFF

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Class I or II recommendations for permanent pacing due to SND, with or without AV block according to the current guidelines;
  • Patients for whom dual-chamber pacing is indicated or preferred;
  • Patients with an optimized and stable antiarrhythmic medical therapy at the time of enrolment;
  • Closed Loop Stimulation function was not previously activated;
  • No stroke events from implant;
  • Patient implanted for the first time;

You may not qualify if:

  • Permanent AF (PermAF)
  • NYHA Class IV Heart Failure
  • Stage V kidney dysfunction
  • Any indication to Cardiac Resynchronization Therapy (CRT)
  • Life expectancy \< 1
  • Minors
  • Pregnant or breast-feeding patients
  • Participation in another interventional trial
  • Atrial fibrillation ablation (left pulmonary veins) or other cardiac surgery \< 3 m

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (54)

Wuhan Asia Heart Hospital

Wuhan, Jinghan District, 430022, China

Location

The 2nd Affiliated Hospital of Harbin Medical University

Harbin, Nangang District, China

Location

Xuanwu Hospital Capital Medical University

Beijing, West City District, 100053, China

Location

Semmelweis University Heart and Vascular Center

Budapest, 1122, Hungary

Location

Max Super Speciality Hospital

New Delhi, 110017, India

Location

Ospedali Riuniti di Ancona

Torrette, Ancona, 60126, Italy

Location

Ospedale Generale Regionale "F. Miulli"

Acquaviva delle Fonti, Bari, 70021, Italy

Location

Ospedale "Bolognini"

Seriate, Bergamo, Italy

Location

Presidio Ospedaliero Ospedale Sant'Anna

San Fermo della Battaglia, Como, 22020, Italy

Location

Ospedale Civile SS. Annunziata

Savigliano, Cuneo, 12038, Italy

Location

Ospedale di Rho

Rho, Italia, 20017, Italy

Location

Ospedale F. Ferrari

Casarano, Lecce, Italy

Location

Ospedale Maria SS Addolorata

Eboli, Salerno, 84025, Italy

Location

Ospedale Santa Maria della Stella

Orvieto, Terni, 05018, Italy

Location

Ospedale di Conegliano

Conegliano, Treviso, 31015, Italy

Location

Azienda Ospedaliera Policlinico Consorziale

Bari, Italy

Location

Ospedale Antonio Cardarelli

Campobasso, 86100, Italy

Location

Azienda Ospedaliera di Caserta Sant'Anna e San Sebastiano

Caserta, Italy

Location

A.O.U. Policlinico Vittorio Emanuele

Catania, Italy

Location

Ospedale Santa Maria Nuova

Florence, 50122, Italy

Location

Ospedale Fabrizio Spaziani

Frosinone, Italy

Location

ASST Valle Olona - Ospedale Sant'Antonio Abate

Gallarate, Italy

Location

ASST RHODENSE - Ospedale Guido Salvini

Garbagnate, Italy

Location

Ospedale Ferdinando Veneziale

Isernia, 86170, Italy

Location

Ospedale Vito Fazzi

Lecce, 73100, Italy

Location

Nuovo Ospedale delle Apuane

Massa, 54100, Italy

Location

Ospedale V. Monaldi

Napoli, 80131, Italy

Location

A.O.P. Federico II

Napoli, Italy

Location

A.O.U Maggiore della Carità di Novara

Novara, 28100, Italy

Location

Azienda Ospedaliera di Padova

Padua, Italy

Location

Ospedale S. Maria della Misericordia

Perugia, Italy

Location

Nuovo Ospedale Santo Stefano

Prato, 59100, Italy

Location

Ospedale "Maria Paternò Arezzo"

Ragusa, 97100, Italy

Location

Ospedale Infermi di Rimini

Rimini, 47923, Italy

Location

Policlinico Umberto I

Roma, 00161, Italy

Location

Policlinico Casilino

Roma, 00169, Italy

Location

Fondazione Policlinico Universitario Agostino Gemelli

Rome, Italy

Location

Azienda Ospedaliera "S. Maria" di Terni

Terni, 05100, Italy

Location

Ospedale di Treviso

Treviso, 31100, Italy

Location

Hospital Serdang

Kajang, 43000, Malaysia

Location

National Heart Center Singapore

Singapore, 169609, Singapore

Location

Tan Tock Seng Hospital

Singapore, 308433, Singapore

Location

Sejong General Hospital

Bucheon-si, 14154, South Korea

Location

Soon Chun Hyang University Hospital Bucheon

Bucheon-si, South Korea

Location

Seul National University Bundang Hospital

Gyeonggi-do, South Korea

Location

Korea University Anam Hospital

Seoul, 02841, South Korea

Location

Seul National University Hospital

Seoul, 03080, South Korea

Location

Pusan National University Yangsan Hospital

Yangsan, South Korea

Location

Hospital General Universitario de Alicante

Alicante, Spain

Location

Hospital Universitario 12 de Octubre

Madrid, 28041, Spain

Location

China Medical University Hospital

Taichung, 40447, Taiwan

Location

National Cheng Kung University Hospital

Tainan, Taiwan

Location

Chang Gung Memorial Hospital

Taipei, Taiwan

Location

National Taiwan University Hospital

Taipei, Taiwan

Location

Related Publications (9)

  • Puglisi A, Altamura G, Capestro F, Castaldi B, Critelli G, Favale S, Pavia L, Pettinati G. Impact of Closed-Loop Stimulation, overdrive pacing, DDDR pacing mode on atrial tachyarrhythmia burden in Brady-Tachy Syndrome. A randomized study. Eur Heart J. 2003 Nov;24(21):1952-61. doi: 10.1016/j.ehj.2003.08.011.

  • Puglisi A, Favale S, Scipione P, Melissano D, Pavia L, Ascani F, Elia M, Scaccia A, Sagone A, Castaldi B, Musacchio E, Botto GL; Burden II Study Group. Overdrive versus conventional or closed-loop rate modulation pacing in the prevention of atrial tachyarrhythmias in Brady-Tachy syndrome: on behalf of the Burden II Study Group. Pacing Clin Electrophysiol. 2008 Nov;31(11):1443-55. doi: 10.1111/j.1540-8159.2008.01208.x.

  • Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575.

  • Russo V, Rago A, Papa AA, Golino P, Calabro R, Russo MG, Nigro G. The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. Heart. 2013 Nov;99(21):1609-13. doi: 10.1136/heartjnl-2013-303878. Epub 2013 May 30.

  • de Cock CC, Giudici MC, Twisk JW. Comparison of the haemodynamic effects of right ventricular outflow-tract pacing with right ventricular apex pacing: a quantitative review. Europace. 2003 Jul;5(3):275-8. doi: 10.1016/s1099-5129(03)00031-x.

  • Lieberman R, Grenz D, Mond HG, Gammage MD. Selective site pacing: defining and reaching the selected site. Pacing Clin Electrophysiol. 2004 Jun;27(6 Pt 2):883-6. doi: 10.1111/j.1540-8159.2004.00551.x.

  • Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, McAnulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes NA 3rd, Greenspon A, Goldman L; Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002 Jun 13;346(24):1854-62. doi: 10.1056/NEJMoa013040.

  • Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med. 2000 May 11;342(19):1385-91. doi: 10.1056/NEJM200005113421902.

  • Toff WD, Camm AJ, Skehan JD; United Kingdom Pacing and Cardiovascular Events Trial Investigators. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med. 2005 Jul 14;353(2):145-55. doi: 10.1056/NEJMoa042283.

MeSH Terms

Conditions

Sick Sinus SyndromeAtrial FibrillationStrokeHeart Failure

Condition Hierarchy (Ancestors)

Arrhythmia, SinusArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesHeart BlockCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2015

First Posted

October 20, 2015

Study Start

September 1, 2015

Primary Completion

March 1, 2023

Study Completion

December 1, 2023

Last Updated

January 18, 2024

Record last verified: 2024-01

Locations